453
Participants
Start Date
February 23, 2015
Primary Completion Date
February 23, 2017
Study Completion Date
February 23, 2017
CD5789 (trifarotene)
Galderma Investigational Site, Pécel
Galderma Investigational Site, Miskolc
Galderma Investigational Site, Szolnok
Galderma Investigational Site, Szeged
Galderma Investigational Site, Szekszárd
Galderma Investigational Site, Balatonfüred
Galderma Investigational Site, Berlin
Galderma Investigational Site, New York
Galderma Investigational Site, Berlin
Galderma Investigational Site, Mahlow
Galderma Investigational Site, High Point
Galderma Investigational Site, Newnan
Galderma Investigational Site, Miramar
Galderma Investigational Site, Miami
Galderma Investigational Site, Mobile
Galderma Investigational Site, Knoxville
Galderma Investigational Site, Louisville
Galderma Investigational Site, Wuppertal
Galderma Investigational Site, Beachwood
Galderma Investigational Site, Münster
Galderma Investigational Site, Rogers
Galderma Investigational Site, Augsburg
Galderma Investigational Site, Albuquerque
Galderma Investigational Site, San Diego
Galderma Investigational Site, Sacramento
Galderma Investigational Site, Portland
Galderma Investigational Site, Chomutov
Galderma Investigational site, Hradec Králové
Galderma Investigational Site, Olomouc
Galderma Investigational Site, Pardubice
Galderma Investigational site, Prague
Galderma Investigational Site, Dessau
Lead Sponsor
Galderma R&D
INDUSTRY